Study of the Safety & PK of INX-08189 in Chronically-infected HCV, Treatment-naïve Subjects
Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the Safety and Pharmacokinetics of Multiple
Ascending Oral Doses of INX-08189 in Chronically-infected Genotype 1 HCV, Treatment-naïve
Subjects.